Guidelines for the indications to test for and to treat Helicobacter pylori infection: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 5: | Line 5: | ||
==2017 ACG guidelines for the indications to test for and to treat Helicobacter pylori infection== | ==2017 ACG guidelines for the indications to test for and to treat Helicobacter pylori infection== | ||
{|class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | | colspan="1" style="text-align:center; background:LightGreen" |[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | ||
|- | |- | ||
| bgcolor="LightGreen"| | | bgcolor="LightGreen" |1.Since all patients with a positive test of active infection with H. pylori should be offered treatment, the critical issue is which patients should be tested for the | ||
infection . | |||
|- | |- | ||
| bgcolor="LightGreen"| | | bgcolor="LightGreen" |2.All patients with active peptic ulcer disease (PUD), a past history of PUD (unless previous cure of H. pylori infection has been documented), low-grade | ||
gastric mucosa-associated lymphoid tissue (MALT) lymphoma, or a history of endoscopic resection of early gastric cancer (EGC) should be tested for H. | |||
pylori infection. Those who test positive should be offered treatment for the infection. | |||
|- | |- | ||
| bgcolor="LightGreen"| | | bgcolor="LightGreen" |'''3.''' When upper endoscopy is undertaken in patients with dyspepsia, gastric biopsies should be taken to evaluate for H. pylori infection. Infected patients | ||
should be offered eradication therapy . | |||
|- | |||
|Patients with typical symptoms of gastroesophageal refl ux disease (GERD) who do not have a history of PUD need not be tested for H. pylori infection. | |||
However, for those who are tested and found to be infected, treatment should be offered, acknowledging that effects on GERD symptoms are unpredictable | |||
|- | |- | ||
|} | |} |
Revision as of 23:56, 30 November 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2], Sargun Singh Walia M.B.B.S.[3]
2017 ACG guidelines for the indications to test for and to treat Helicobacter pylori infection
Class I |
1.Since all patients with a positive test of active infection with H. pylori should be offered treatment, the critical issue is which patients should be tested for the
infection . |
2.All patients with active peptic ulcer disease (PUD), a past history of PUD (unless previous cure of H. pylori infection has been documented), low-grade
gastric mucosa-associated lymphoid tissue (MALT) lymphoma, or a history of endoscopic resection of early gastric cancer (EGC) should be tested for H. pylori infection. Those who test positive should be offered treatment for the infection. |
3. When upper endoscopy is undertaken in patients with dyspepsia, gastric biopsies should be taken to evaluate for H. pylori infection. Infected patients
should be offered eradication therapy . |
Patients with typical symptoms of gastroesophageal refl ux disease (GERD) who do not have a history of PUD need not be tested for H. pylori infection.
However, for those who are tested and found to be infected, treatment should be offered, acknowledging that effects on GERD symptoms are unpredictable |